Skip to content

PACS Group PACS Deferred Tax Liabilities, Property, Plant and Equipment

Deferred Tax Liabilities, Property, Plant and Equipment at other companies

Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY

Other financials

Income statement

See full
Revenue$1.4B+11.2%
Gross profit$346.0M+36.5%
Operating income$120.0M+149%
Net income$80.7M+183%
EPS (diluted)$0.50+194%

Balance sheet

See full
Cash & equivalents$273.7M-5.8%
Total debt$3.5B-3.2%
Total equity$1.0B+38.2%
Total assets$5.7B+3.1%

Cash flow

See full
Operating cash flow$236.3M+57.3%
CapEx$21.8M+23.2%
Free cash flow$214.5M+61.9%

Valuation

See full
Market cap$5.91B+189%

Profitability

See full
Gross margin23%+3.7pp
Operating margin7%+4.6pp
Net margin4.5%+3.4pp
FCF margin7.7%

Returns & leverage

See full
Return on equity27.3%+15.8pp
Debt / equity3.3×-1.4×
Current ratio0.0×

Where this comes from

Reported directly by PACS Group in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment.

The official record: PACS Group’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about PACS Group's deferred tax liabilities, property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PACS Group's deferred tax liabilities, property, plant and equipment?
PACS Group (PACS) reported deferred tax liabilities, property, plant and equipment of $65.66M in Q4 2025.
What is the long-term trend for PACS Group's deferred tax liabilities, property, plant and equipment?
Over 2 years (2023 to 2025), PACS Group's deferred tax liabilities, property, plant and equipment has grown at a 33.5% compound annual growth rate (CAGR), from $36.84M to $65.66M.